No abstract available
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antirheumatic Agents / therapeutic use*
-
Arthritis, Psoriatic / drug therapy*
-
Clinical Trials, Phase III as Topic
-
Humans
-
Treatment Failure
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Ustekinumab
Substances
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Ustekinumab